Weiss Multi-Strategy Advisers’s Audentes Therapeutics BOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
– Sell
-122,833
Closed -$7.35M – 718
2019
Q4
$7.35M Buy
+122,833
New +$4.61M 0.12% 237

Weiss Multi-Strategy Advisers's BOLD Position: Q1 2020 in Review

Weiss Multi-Strategy Advisers sold out of Audentes Therapeutics (BOLD) in Q1 2020, closing a stake of 122,833 shares — an estimated $7.35M sold.

Weiss Multi-Strategy Advisers first reported a position in BOLD in Q4 2019 and held it in 1 quarter. The position peaked at $7.35M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

  • Weiss Multi-Strategy Advisers reported no remaining Audentes Therapeutics position as of Q1 2020 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 122,833 Audentes Therapeutics shares in Q1 2020, an estimated $7.35M.
  • Weiss Multi-Strategy Advisers first reported a position in Audentes Therapeutics in Q4 2019 and held it in 1 quarter.
  • Weiss Multi-Strategy Advisers's Audentes Therapeutics position peaked at $7.35M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Audentes Therapeutics as of Q1 2020.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2020, filed 15 May 2020.